Vir Biotechnology Company
Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Technology:
Cell-based gene therapy
Industry:
Public
Headquarters:
San Francisco, California, United States
Founded Date:
2016-04-07
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
6
Total Funding:
793600000
Estimated Revenue:
$1B to $10B
Last Funding Date:
2020-04-07
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership